BAKER BROS. ADVISORS LP Insider Trading Activity

Average Profitability
12.01%
Insider Buys Quantity
121
Insider Buys Sum
$2.27B
Insider Sells Quantity
20
Insider Sells Sum
$88.3M

Insider Activity of BAKER BROS. ADVISORS LP

According to the SEC Form 4 filings, BAKER BROS. ADVISORS LP, being in a position of

  1. director at BeOne Medicines AG,
    оver the last 12 months, has bought 0 shares, and sold 10998 shares for $261,981,
    over all time since 2025-02-28, has bought 0 shares, and sold 743825 shares for $190.8M.

Biography of BAKER BROS. ADVISORS LP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $391,100,753880
Sells
 $318,011,981220

Comparison of Insiders on Amount of Buys and Sells

2026-09-29PurchaseKodiak Sciences Inc.
KOD
33,726
0.0503%
$85.05$2.87M+2.03%
2026-09-28PurchaseKodiak Sciences Inc.
KOD
1.91M
2.7367%
$80.77$154.12M+3.04%
2026-07-14SaleCelcuity Inc.
CELC
Former 10% owner
3.1M
5.8674%
$102.50$317.75M-24.36%
2026-05-22SaleBeOne Medicines Ltd.
ONC
director
10,998
0.0008%
$23.82$261,981+12.25%
2025-12-18PurchaseKodiak Sciences Inc.
KOD
2.61M
4.2971%
$23.00$60M+40.33%
2025-12-11PurchaseKymera Therapeutics, Inc.
KYMR
2.01M
2.7299%
$86.00$172.5M-0.5%
2025-11-20PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
28,867
0.0747%
$9.07$261,846-17.01%
2025-11-12PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
100,736
0.296%
$7.76$781,638-3.68%
2025-11-11PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
46,434
0.1318%
$7.50$348,193+0.26%
2025-11-10PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
30,874
0.0844%
$7.21$222,756+6.27%
2025-10-01SaleKALA BIO, Inc.
KALA
Former 10% owner
513,607
6.6162%
$1.38$710,729-85.37%
2025-09-30SaleKALA BIO, Inc.
KALA
Former 10% owner
216,801
3.2209%
$1.60$345,993-86.93%
2025-09-08PurchaseCelcuity Inc.
CELC
10 percent owner
170,100
0.3608%
$56.27$9.57M+61.76%
2025-08-20PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
59,901
0.2643%
$385.16$23.07M+29%
2025-08-18PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
105,782
0.4453%
$367.26$38.85M+28.37%
2025-06-30PurchaseKymera Therapeutics, Inc.
KYMR
director
655,500
1.0149%
$44.00$28.84M+67.76%
2025-03-17PurchaseImmunocore Holdings plc
IMCR
director
807,338
1.5953%
$29.72$23.99M+9.82%
2025-02-28SaleBeOne Medicines Ltd.
ONC
director
732,827
0.5331%
$260.00$190.54M+13.7%
2024-12-30PurchaseKala Pharmaceuticals, Inc.
KALA
10 percent owner
310,559
6.2153%
$6.44$2M-30.06%
2024-12-16PurchaseBicycle Therapeutics plc
BCYC
500,000
0.7341%
$15.34$7.67M-46.3%
Total: 132
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.